论文部分内容阅读
甲状腺结节是最常见的疾病之一,其精确诊断对于患者的有效临床管理十分重要。分子标志物是一项非常有效的诊断和预后评估工具,尤其在细胞学不确定的甲状腺癌结节。近年来,分子标志物的临床应用发展已经取得显著的进步。随着新一代基因检测技术的发展,能够同时检测多个基因,这不仅可为甲状腺癌的诊断提供依据,而且也可为预测甲状腺癌患者的预后提供参考,本文就甲状腺癌的诊断及预后相关的分子标志物进行综述。
Thyroid nodules are one of the most common diseases, and their precise diagnosis is very important for the effective clinical management of patients. Molecular markers are a very effective diagnostic and prognostic tool, especially in cytologically undefined thyroid cancer nodules. In recent years, the clinical application of molecular markers has made significant progress. With the development of a new generation of genetic testing technology, the simultaneous detection of multiple genes can not only provide a basis for the diagnosis of thyroid cancer, but also provide a reference for predicting the prognosis of thyroid cancer patients. In this paper, the diagnosis and prognosis of thyroid cancer The molecular markers are reviewed.